Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DTX2P1-UPK3BP1-PMS2P11 readthrough, transcribed pseudogene |
|
phenotype | 0.100 | None | 1.000 | 8 | 5 | 2015 | 2019 | |||||||||||
|
NYN domain and retroviral integrase containing | 1.5E-09 |
|
phenotype | 0.100 | None | 1.000 | 8 | 4 | 2010 | 2019 | ||||||||||
|
leucine rich repeat containing 10B | 4.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 6 | 3 | 2016 | 2018 | ||||||||||
|
ral guanine nucleotide dissociation stimulator like 3 | 1.0E-31 |
|
phenotype | 0.100 | None | 1.000 | 6 | 2 | 2016 | 2019 | ||||||||||
|
sorting nexin 13 | 0.40 |
|
phenotype | 0.100 | None | 1.000 | 5 | 4 | 2013 | 2019 | ||||||||||
|
DnaJ heat shock protein family (Hsp40) member C16 | 3.6E-11 |
|
phenotype | 0.100 | None | 1.000 | 5 | 6 | 2016 | 2019 | ||||||||||
|
leucine rich repeat containing 10B | 4.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2016 | 2019 | ||||||||||
|
CHURC1-FNTB readthrough | 5.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 4 | 2 | 2012 | 2019 | ||||||||||
|
long intergenic non-protein coding RNA 2227 |
|
phenotype | 0.100 | None | 1.000 | 4 | 5 | 2017 | 2019 | |||||||||||
|
zinc finger protein 483 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2010 | 2019 | ||||||||||
|
chymotrypsin like elastase 2B | 2.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 4 | 3 | 2017 | 2019 | ||||||||||
|
penta-EF-hand domain containing 1 | 1.5E-04 |
|
phenotype | 0.100 | None | 1.000 | 4 | 5 | 2017 | 2019 | ||||||||||
|
transmembrane and coiled-coil domain family 2 | 0.29 |
|
phenotype | 0.100 | None | 1.000 | 4 | 5 | 2009 | 2016 | ||||||||||
|
SEMA3F antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2017 | 2019 | |||||||||||
|
CHURC1-FNTB readthrough | 5.3E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2009 | 2017 | ||||||||||
|
GSTCD antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2010 | 2017 | |||||||||||
|
DC-STAMP domain containing 2 | 1.8E-12 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2018 | 2019 | ||||||||||
|
chromosome 2 open reading frame 73 | 3.7E-07 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2019 | 2019 | ||||||||||
|
germinal center associated signaling and motility like | 0.12 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2011 | 2016 | ||||||||||
|
TMEM72 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | |||||||||||
|
SEC14 like lipid binding 4 | 1.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||||
|
SEC14 like lipid binding 4 | 1.3E-11 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 | ||||||||||
|
NFKB inhibitor interacting Ras like 1 | 5.0E-04 |
|
phenotype | 0.100 | None | 1.000 | 3 | 8 | 2018 | 2019 | ||||||||||
|
leucine rich repeat containing 10B | 4.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2015 | 2018 | ||||||||||
|
SLC2A1 antisense RNA 1 | 1.000 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2016 | 2019 |